COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

Proposed legislation would forgive student loan debt for frontline healthcare workers battling COVID-19

New legislation has been introduced that would forgive student loan debt for frontline healthcare workers who have provided patient care during the ongoing COVID-19 pandemic.

Thumbnail

Blood thinners improve outcomes for hospitalized COVID-19 patients

Is it time to start routinely treating COVID-19 patients with anticoagulants?

Thumbnail

What new research tells us about key blood pressure medications and COVID-19

Antihypertensive medications don’t increase a person’s risk of testing positive for COVID-19, according to new research published in the New England Journal of Medicine.

Thumbnail

A potential risk: New studies highlight the connection between treating COVID-19 with hydroxychloroquine and QTc prolongation

Treating COVID-19 patients with hydroxychloroquine, alone or in combination with azithromycin, is associated with an increased risk of QTc prolongation, according to two new studies published in JAMA Cardiology.

Thumbnail

Cardiovascular groups share joint guidance on continuation of procedures, diagnostic tests during COVID-19 pandemic

A group of cardiovascular societies, including the American College of Cardiology (ACC) and American Heart Association (AHA), has published a new guidance designed to help providers resume important procedures and diagnostic tests during the COVID-19 pandemic.

Thumbnail

American Heart Association dedicates another $2M to COVID-19 research

“We were just blown away and so impressed to see this level of interest and commitment from the teams submitting such thorough proposals so quickly,” said AHA President Robert A. Harrington, MD.

Thumbnail

Novartis launches FDA-approved study involving hydroxychloroquine, azithromycin, COVID-19 patients

Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine.

Thumbnail

What high COVID-19 mortality among black patients tells us about CVD care in the US

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

Displaying 377 - 384 of 427

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.